Ludwig H - Search Results

1

[Interferon in the treatment of multiple myeloma].

Kuzmits R, Ludwig H, Cortelezzi A, Van Camp BG, Polli E, Flener R, Scheithauer W. Kuzmits R, et al. Among authors: ludwig h. Acta Med Austriaca. 1985;12(5):135-8. Acta Med Austriaca. 1985. PMID: 3914174 Clinical Trial. German.

2

[Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].

Kuzmits R, Scheithauer W, Ludwig H, Flener R. Kuzmits R, et al. Among authors: ludwig h. Acta Med Austriaca. 1985;12(5):129-34. Acta Med Austriaca. 1985. PMID: 3938590 German.

3

Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.

Ludwig H, Cortelezzi A, Van Camp BG, Polli E, Scheithauer W, Kuzmits R, Linkesch W, Gisslinger H, Sinzinger H, Fritz E, et al. Ludwig H, et al. Oncology. 1985;42 Suppl 1:19-25. doi: 10.1159/000226080. Oncology. 1985. PMID: 4080297 Clinical Trial.

4

Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.

Ludwig H, Cortelezzi A, Scheithauer W, Van Camp BG, Kuzmits R, Fillet G, Peetermans M, Polli E, Flener R. Ludwig H, et al. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1111-6. doi: 10.1016/0277-5379(86)90015-5. Eur J Cancer Clin Oncol. 1986. PMID: 3536528 Free article. Clinical Trial.

5

[Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].

Linkesch W, Gisslinger H, Ludwig H, Flener R, Sinzinger H. Linkesch W, et al. Among authors: ludwig h. Acta Med Austriaca. 1985;12(5):123-7. Acta Med Austriaca. 1985. PMID: 3914173 Clinical Trial. German.

6

Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.

Scheithauer W, Cortelezzi A, Fritz E, Kührer I, Polli E, Baldini L, Ludwig H. Scheithauer W, et al. Among authors: ludwig h. J Biol Response Mod. 1989 Apr;8(2):109-15. J Biol Response Mod. 1989. PMID: 2659740 Clinical Trial.

7

[Interferon therapy in multiple myeloma].

Ludwig H, Scheithauer W, Kührer I, Kuzmits R, Gisslinger G, Linkesch W, Zielinski C, Fritz E. Ludwig H, et al. Onkologie. 1988 Aug;11(4):192-6. doi: 10.1159/000216520. Onkologie. 1988. PMID: 3054670 German.

8

VAD protocol for treatment of advanced refractory multiple myeloma.

Scheithauer W, Cortelezzi A, Kutzmits R, Baldini L, Ludwig H. Scheithauer W, et al. Among authors: ludwig h. Blut. 1987 Sep;55(3):145-52. doi: 10.1007/BF00320568. Blut. 1987. PMID: 3620710

9

Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma.

Kuzmits R, Kokoschka EM, Micksche M, Ludwig H, Flener R. Kuzmits R, et al. Among authors: ludwig h. Oncology. 1985;42 Suppl 1:26-32. doi: 10.1159/000226081. Oncology. 1985. PMID: 4080298

10

Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies.

Janssen JT, Ludwig H, Scheithauer W, de Pauw BE, Keyser A, van Tol R, Flener R. Janssen JT, et al. Among authors: ludwig h. Oncology. 1985;42 Suppl 1:3-6. doi: 10.1159/000226075. Oncology. 1985. PMID: 4080299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,119 results

Search Page

Filters